<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Few studies have focused on the relationship between hormone replacement therapy (HRT) for postmenopausal women or those with <z:hpo ids='HP_0003002'>breast cancer</z:hpo> and the occurrence of <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Results are conflicting as to whether there is a link between the two </plain></SENT>
<SENT sid="2" pm="."><plain>We describe three patients who experienced <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> during HRT </plain></SENT>
<SENT sid="3" pm="."><plain>A 73-year-old woman had a <z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> (<z:hpo ids='HP_0002326'>TIA</z:hpo>) 6 years prior to the present admission </plain></SENT>
<SENT sid="4" pm="."><plain>She then took HRT <z:chebi fb="67" ids="50114">oestrogen</z:chebi> plus <z:chebi fb="0" ids="6716">medroxyprogesterone acetate</z:chebi> for about 6 years </plain></SENT>
<SENT sid="5" pm="."><plain>The HRT had been prescribed by a gynaecologist for amelioration of <z:e sem="disease" ids="C0747771" disease_type="Disease or Syndrome" abbrv="">postmenopausal symptoms</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Six years after beginning HRT, she experienced sudden <z:hpo ids='HP_0003674'>onset</z:hpo> left <z:hpo ids='HP_0001269'>hemiparesis</z:hpo> due to <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Two other patients had been taking HRT for <z:hpo ids='HP_0003002'>breast cancers</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>One, a 47-year-old woman, had taken <z:chebi fb="0" ids="6716">medroxyprogesterone acetate</z:chebi> for more than one year, for recurrence of <z:hpo ids='HP_0003002'>breast cancer</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>She had developed sudden complete left <z:hpo ids='HP_0001269'>hemiparesis</z:hpo> due to an embolism at the carotid bifurcation </plain></SENT>
<SENT sid="10" pm="."><plain>The other patient, a 72-year-old woman who was taking <z:chebi fb="0" ids="9397">tamoxifen citrate</z:chebi> for prevention of <z:hpo ids='HP_0003002'>breast cancer</z:hpo> relapse, experienced <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> just 2 months after beginning <z:chebi fb="3" ids="41774">tamoxifen</z:chebi> </plain></SENT>
<SENT sid="11" pm="."><plain>The risk of <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> in those on HRT should be emphasized, along with the beneficial effects in terms of <z:e sem="disease" ids="C0747771" disease_type="Disease or Syndrome" abbrv="">postmenopausal symptoms</z:e> and prevention of <z:hpo ids='HP_0003002'>breast cancer</z:hpo> recurrence </plain></SENT>
</text></document>